tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals Inc. (DE:VX1)
:VX1
Germany Market

Vertex Pharmaceuticals (VX1) Cash flow

Compare
23 Followers

Vertex Pharmaceuticals Cash Flow

DE:VX1's free cash flow for Q3 2025 was $1.14B. For the 2025 fiscal year, DE:VX1's free cash flow was decreased by $-4.07B and operating cash flow was $1.24B. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -492.60M$ 3.54B$ 4.13B$ 2.64B$ 3.25B
Investing Cash Flow
$ -3.77B$ -3.14B$ -321.10M$ -340.90M$ 99.39M
Financing Cash Flow
$ -1.49B$ -562.20M$ -67.70M$ -1.48B$ -505.28M
End Cash Position
$ 4.57B$ 10.37B$ 10.51B$ 6.80B$ 5.99B
Free Cash Flow
$ -790.30M$ 3.28B$ 3.93B$ 2.41B$ 2.99B
Currency in USD

Vertex Pharmaceuticals Cash Flow